BOSTON and YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- Butterfly Medical, developer of a proprietary non-surgical solution for benign prostatic hyperplasia (BPH), today announced the successful ...
An enlarged prostate is a big problem for men, no pun intended. According to Yale Medicine, about 50% of men between the ages of 51 and 60 have benign prostatic hyperplasia (BPH) or an enlarged ...
BOSTON and YOKNEAM, Israel, April 22, 2025 /PRNewswire/ -- Butterfly Medical, a medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), announced ...
Cleveland Clinic Urologist Dr. James Ulchaker will Support Efforts Toward FDA Approval and U.S. Commercialization While Contributing to Medical Strategy and Patient-Focused Care BPH affects up to 50 ...
Nevada Sanchez, co-founder of Butterfly Network, talks to Machine Design about the organization making life-saving technology available to frontline healthcare workers in the developing world. In ...
Butterfly Network announced Tuesday that it has signed a deal with the Medical University of South Carolina (MUSC) to provide its point-of-care ultrasound devices and software to the organization, ...
Butterfly Network has selected the medical robotics startup Mendaera to serve as the first participant in its ultrasound hardware commercialization program. The pair aims to deliver an interventional ...
The MarketWatch News Department was not involved in the creation of this content. Results of 244-Patient Study to Support Planned FDA Pre-Market Approval (PMA) Application BOSTON and YOKNEAM, Israel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results